Ironwood Pharmaceuticals Inc Earnings

The next earnings date for Ironwood Pharmaceuticals Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Ironwood Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$0.11

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Ironwood Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$0.14	438.46%
05/07/2025	Before Market	$-0.14	-170.00%
02/13/2025	Before Market	$0.02	-74.19%
11/07/2024	Before Market	$0.02	-75.00%
08/08/2024	Before Market	$-0.01	-103.60%
05/09/2024	Before Market	$-0.02	-110.53%
02/15/2024	Before Market	$-0.01	-104.76%
11/09/2023	Before Market	$0.09	-43.75%
08/08/2023	Before Market	$0.31	24.00%
05/04/2023	Before Market	$0.25	4.17%
02/16/2023	Before Market	$0.27	0.00%
11/03/2022	Before Market	$0.28	3.70%
08/04/2022	Before Market	$0.21	-30.00%
05/05/2022	Before Market	$0.21	-19.23%
02/17/2022	Before Market	$0.27	-22.86%
11/04/2021	Before Market	$0.33	6.45%
08/05/2021	Before Market	$0.34	47.83%
05/06/2021	Before Market	$0.24	14.29%
02/17/2021	Before Market	$0.36	24.14%
11/05/2020	After Market	$0.23	53.33%
08/06/2020	Before Market	$0.16	77.78%
05/06/2020	After Market	$0.04	-20.00%
02/13/2020	Before Market	$0.30	25.00%
10/31/2019	Before Market	$0.40	263.64%
07/30/2019	After Market	$0.10	433.33%
05/02/2019	Before Market	$-0.26	-85.71%
02/13/2019	Before Market	$-0.02	86.67%
11/06/2018	Before Market	$-0.38	-123.53%
08/06/2018	Before Market	$-0.28	-33.33%
05/01/2018	Before Market	$-0.27	-17.39%
02/15/2018	Before Market	$-0.14	22.22%
11/02/2017	Before Market	$-0.18	18.18%
08/03/2017	After Market	$-0.30	-36.36%
05/08/2017	Before Market	$-0.36	-80.00%
02/21/2017	After Market	$-0.09	62.50%
11/03/2016	Before Market	$-0.23	0.00%
08/04/2016	After Market	$-0.14	6.67%
05/09/2016	After Market	$-0.09	30.77%
02/18/2016	After Market	$-0.09	47.06%
11/03/2015	After Market	$-0.25	-25.00%
08/05/2015	After Market	$-0.34	-54.55%
05/05/2015	After Market	$-0.24	-4.35%
02/12/2015	After Market	$-0.27	-28.57%
11/04/2014	After Market	$-0.30	6.25%
08/04/2014	---	$-0.44	-22.22%
04/29/2014	---	$-0.38	11.63%
01/21/2014	---	$-0.43	14.00%
10/22/2013	---	$-0.51	10.53%
07/23/2013	---	$-0.57	16.18%
04/23/2013	---	$-0.82	-28.13%
01/15/2013	---	$-0.41	12.77%
10/16/2012	---	$0.42	223.08%
07/17/2012	---	$-0.38	-18.75%
05/01/2012	---	$-0.34	-41.67%
02/28/2012	---	$-0.07	36.36%
11/07/2011	---	$-0.21	0.00%
08/11/2011	---	$-0.19	0.00%
05/12/2011	---	$-0.19	-11.76%
03/03/2011	---	$-0.12	14.29%
11/04/2010	---	$-0.08	57.89%
08/05/2010	---	$-0.18	5.26%
05/11/2010	---	$-0.25	-56.25%
03/30/2010	---	$-3.30	-1,550.00%

More About Ironwood Pharmaceuticals Inc

Website

https://ironwoodpharma.com

Country

USA

Full Time Employees

253

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 for short bowel syndrome patients dependent on parenteral support, as well as for acute graft versus host disease. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

“Ironwood Pharmaceuticals Inc Earnings” Can Refer to the Ironwood Pharmaceuticals Inc Earnings Date

Some people say “Ironwood Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Ironwood Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Ironwood Pharmaceuticals Inc Stock on the Earnings Date

If you own Ironwood Pharmaceuticals Inc stock (IRWD) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Ironwood Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Ironwood Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Ironwood Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Ironwood Pharmaceuticals Inc earnings or anything else related to the stock market.